Kangmei Pharmaceutical Co Ltd
SSE:600518
Wall Street
Price Targets
Price Targets Summary
Kangmei Pharmaceutical Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Kangmei Pharmaceutical Co Ltd's stock price target?
Not Available
Kangmei Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Kangmei Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
36%
For the last 13 years the
compound annual growth rate for
Kangmei Pharmaceutical Co Ltd's revenue is
-1%.
The projected
CAGR
for the next 6 years is
36%.
What is Kangmei Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
241%
For the last 13 years the
compound annual growth rate for
Kangmei Pharmaceutical Co Ltd's net income is
-31%.
The projected
CAGR
for the next 6 years is
241%.